|
ARHGAP29 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.447100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.029900E-02 |
| Normal-vs-Stage2 |
4.695700E-03 |
| Normal-vs-Stage3 |
4.3620000000022E-05 |
| Normal-vs-Stage4 |
1.55847999999681E-05 |
| Stage1-vs-Stage2 |
6.436500E-02 |
| Stage1-vs-Stage3 |
1.587410E-04 |
| Stage1-vs-Stage4 |
3.55990000000528E-05 |
| Stage2-vs-Stage3 |
5.995000E-01 |
| Stage2-vs-Stage4 |
3.232600E-01 |
| Stage3-vs-Stage4 |
4.855400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.015060E-03 |
| Normal-vs-AfricanAmerican |
2.373000E-01 |
| Normal-vs-Asian |
5.421600E-01 |
| Caucasian-vs-AfricanAmerican |
3.985800E-01 |
| Caucasian-vs-Asian |
5.050000E-01 |
| AfricanAmerican-vs-Asian |
9.399600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.61879999999971E-05 |
| Normal-vs-Female |
3.388300E-02 |
| Male-vs-Female |
1.882170E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.101400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.336400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.757830E-04 |
| Normal-vs-Age(81-100Yrs) |
9.249700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.108600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.308000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.798370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.474000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.428200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.124400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.978600E-01 |
| Normal-vs-Grade 2 |
2.637200E-01 |
| Normal-vs-Grade 3 |
1.52722999999799E-05 |
| Normal-vs-Grade 4 |
1.32509999994923E-06 |
| Grade 1-vs-Grade 2 |
3.520200E-01 |
| Grade 1-vs-Grade 3 |
2.695900E-02 |
| Grade 1-vs-Grade 4 |
1.277530E-02 |
| Grade 2-vs-Grade 3 |
2.28190000006734E-07 |
| Grade 2-vs-Grade 4 |
4.85339999967138E-07 |
| Grade 3-vs-Grade 4 |
1.861850E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.256200E-01 |
| Normal-vs-ccB subtype |
1.459820E-03 |
| ccA subtype-vs-ccB subtype |
6.676000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.008100E-04 |
| Normal-vs-N1 |
8.483800E-02 |
| N0-vs-N1 |
8.733600E-01 |
|
|
